#United States #New York #Class Action #Wolf Haldenstein #3D Systems

Legal Action Alert for 3D Systems Shareholders

Investors holding 3D Systems (NYSE: DDD) shares should take immediate notice as a securities class action lawsuit has recently been filed. This suit, lodged in the United States District Court for the District of Delaware, addresses concerns regarding misleading statements made by the company during a specified period. The law firm handling the case, Wolf Haldenstein Adler Freeman & Herz LLP, is particularly focused on protecting the rights of shareholders caught in this difficult situation.

Understanding the Class Action Lawsuit

The lawsuit impacts all individuals or entities that purchased or acquired securities from 3D Systems between August 13, 2024, and May 12, 2025. This timeframe, referred to as the Class Period, highlights allegations that the company and certain executives misrepresented critical information. Specific claims include:

• - An underestimation of the negative effects stemming from reduced customer spending, paired with an overstatement of the company’s resilience in a challenging industry climate.
• - Changes in milestone criteria concerning the United Partnership that would likely have negative repercussions on revenues derived from its Regenerative Medicine Program.

Due to these misleading public statements, the company's financial disclosures have been called into serious question.

Financial Disappointments and Consequences

On March 26, 2025, 3D Systems publicly revealed its Q4 and full-year financial results for 2024, which fell short of market expectations. The report indicated:

• - A Q4 non-GAAP EPS of -$0.19, underestimating analyst expectations by $0.08 per share.
• - Year-over-year sales revenue decreased by 3.4%, amounting to $111 million, which also missed estimates by $4.17 million.
• - Full-year revenue for 2024 reached $440.1 million—a 10% drop from the previous year, predominantly due to a decline in hardware system sales.
• - Additional revenue readings indicated a decrease of $9 million in Q4, relating to adjustments in accounting tied to the Regenerative Medicine Program.

As a direct result of these disappointing announcements, the company’s stock plunged nearly 21% on March 27, closing at $2.15 per share. This steep decline left shareholders understandably concerned about their investments.

The situation continued to deteriorate when, on May 12, 2025, 3D Systems announced first-quarter results for 2025, citing a drop in material sales due primarily to inventory management problems affecting the dental segment of its Healthcare Solutions. Furthermore, the company retracted its optimistic outlook for the full year of 2025, citing ongoing economic uncertainties and a protracted slowdown in customer capital investments.

This prompted another sharp decline in stock price, causing shares to fall by approximately 27%, closing at $1.87 per share on May 13, 2025. These events underscore the importance of understanding the financial health and transparency of companies from which shares are held.

Contact Information for Affected Investors

Wolf Haldenstein Adler Freeman & Herz LLP has a long-standing reputation for standing up for investor rights, founded in 1888, and boasts over 125 years of legal expertise in securities litigation. The firm is inviting all investors affected by these troubling circumstances to reach out for assistance.

Affected shareholders are encouraged to act swiftly, especially as the deadline for the lead plaintiff motion is set for August 12, 2025. Interested investors can contact the firm directly at:

• - Phone: (800) 575-0735 or (212) 545-4774
• - Email: [email protected]

For further details about the firm and support available to investors, you can visit the Wolf Haldenstein website.

Remember, timely action is paramount for those who believe they've suffered financial harm as a result of the alleged misrepresentations by 3D Systems. The pursuit of justice is more important than ever in these challenging times.